Skip to main content

Seattle Biotech Company Dendreon Files For Bankruptcy

Ross Reynolds talks to Seattle biotech writer Luke Timmerman about the biotech company Dendreon, which filed for bankruptcy after their prostate cancer drug failed to make a sizable profit.

Why you can trust KUOW
Close
On Air Shows

Print

Print

Play Audio
 Live Now On KUOW
KUOW Live Stream
On Air Shows

Print

Print

Play Audio
Local Newscast
The Latest
View All
    Play Audio